scholarly article | Q13442814 |
P2093 | author name string | M Albert | |
M Adler | |||
J Selva | |||
M Bailly | |||
M Bergere | |||
R Wainer | |||
F Vialard | |||
D Molina Gomes | |||
I Hammoud | |||
L Malagrida | |||
P2860 | cites work | Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS) | Q21245539 |
Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection | Q24244735 | ||
Laser microdissection as a new approach to prefertilization genetic diagnosis | Q30661800 | ||
ESHRE PGD Consortium data collection IV: May-December 2001. | Q30976595 | ||
Outcome of laser-assisted polar body biopsy and aneuploidy testing | Q31122726 | ||
Laser-assisted microdissection of the zona pellucida facilitates polar body biopsy | Q32072970 | ||
Maternal aging and chromosomal abnormalities: new data drawn from in vitro unfertilized human oocytes | Q33185673 | ||
Are zona pellucida laser drilling and polar body biopsy safe for in vitro matured oocytes? | Q33585252 | ||
High follicle-stimulating hormone increases aneuploidy in human oocytes matured in vitro | Q33606372 | ||
Preimplantation diagnosis for aneuploidies in patients undergoing in vitro fertilization with a poor prognosis: identification of the categories for which it should be proposed. | Q33880192 | ||
Maternal age and chromosomally abnormal pregnancies: what we know and what we wish we knew | Q33951926 | ||
Polar body array CGH for prediction of the status of the corresponding oocyte. Part II: technical aspects | Q34015963 | ||
Preimplantation genetic screening: a systematic review and meta-analysis of RCTs | Q34181388 | ||
Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. | Q34357019 | ||
Chromosomal abnormalities in oocytes | Q34384550 | ||
Biomarkers of human oocyte developmental competence expressed in cumulus cells before ICSI: a preliminary study | Q34688490 | ||
Trisomic pregnancy and elevated FSH: implications for the oocyte pool hypothesis | Q35117692 | ||
Prevention of maternal aging-associated oocyte aneuploidy and meiotic spindle defects in mice by dietary and genetic strategies | Q35134078 | ||
Polar body array CGH for prediction of the status of the corresponding oocyte. Part I: clinical results | Q35389273 | ||
Polar body morphology is not predictive of its cell division origin | Q35722529 | ||
Over a decade of experience with preimplantation genetic diagnosis: a multicenter report | Q35859368 | ||
Multiple meiotic errors caused by predivision of chromatids in women of advanced maternal age undergoing in vitro fertilisation | Q36035686 | ||
Preimplantation genetic diagnosis for aneuploidy screening in repeated implantation failure | Q36093458 | ||
Chromosome 21 detection in human oocyte fluorescence in situ hybridization: possible effect of maternal age | Q36268516 | ||
Prevention of age-related aneuploidies by polar body testing of oocytes. | Q36271707 | ||
Embryo aneuploidy screening for repeated implantation failure and unexplained recurrent miscarriage. | Q36527052 | ||
The origin of human aneuploidy: where we have been, where we are going | Q36958145 | ||
Gamete cytogenetic study in couples with implantation failure: aneuploidy rate is increased in both couple members. | Q36995761 | ||
IVF/ICSI with or without preimplantation genetic screening for aneuploidy in couples without genetic disorders: a systematic review and meta-analysis | Q37284506 | ||
Human cumulus cells as biomarkers for embryo and pregnancy outcomes | Q37740724 | ||
Predisposition to aneuploidy in the oocyte | Q37845069 | ||
Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial | Q40254344 | ||
Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology | Q40394248 | ||
The influence of intrinsic and extrinsic factors on the developmental potential and chromosomal normality of the human oocyte. | Q41105279 | ||
Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes. | Q42491370 | ||
Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles | Q42494908 | ||
The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos | Q43132928 | ||
Basal FSH, estradiol and inhibin B concentrations in women with a previous Down's syndrome affected pregnancy | Q43833603 | ||
Follicle-stimulating hormone affects metaphase I chromosome alignment and increases aneuploidy in mouse oocytes matured in vitro | Q45061653 | ||
Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment | Q45234419 | ||
The cytogenetics of polar bodies: insights into female meiosis and the diagnosis of aneuploidy | Q45844850 | ||
Ovarian stimulation and the risk of aneuploid conceptions | Q45984200 | ||
Basal follicle-stimulating hormone as a predictor of fetal aneuploidy | Q46188678 | ||
Perifollicular vascularity in poor ovarian responders during IVF. | Q46952688 | ||
Human cumulus cell gene expression as a biomarker of pregnancy outcome after single embryo transfer. | Q48673269 | ||
Comprehensive chromosome screening of polar bodies and blastocysts from couples experiencing repeated implantation failure | Q48718141 | ||
Chromosomal aneuploidy in embryos conceived with unstimulated cycle IVF. | Q48744843 | ||
Anti-Müllerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization | Q48791608 | ||
Oocyte aneuploidy mechanisms are different in two situations of increased chromosomal risk: older patients and patients with recurrent implantation failure after in vitro fertilization. | Q48793829 | ||
Robust embryo identification using first polar body single nucleotide polymorphism microarray-based DNA fingerprinting | Q48831615 | ||
Chromosomal abnormalities in a series of 6,733 human oocytes in preimplantation diagnosis for age-related aneuploidies. | Q48832214 | ||
Mechanisms of non-disjunction in human female meiosis: the co-existence of two modes of malsegregation evidenced by the karyotyping of 1397 in-vitro unfertilized oocytes | Q48854145 | ||
Experimental evidence that changes in oocyte growth influence meiotic chromosome segregation | Q48861937 | ||
Selection of the most common chromosome abnormalities in oocytes prior to ICSI. | Q48886368 | ||
The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics | Q48958485 | ||
Cigarette smoking may affect meiotic maturation of human oocytes | Q49029679 | ||
First meiosis errors in immature oocytes generated by stimulated cycles. | Q50647697 | ||
Meiotic spindle configuration is differentially influenced by FSH and epidermal growth factor during in vitro maturation of mouse oocytes. | Q50651543 | ||
Evidence of a high proportion of premature unbalanced separation of sister chromatids in the first polar bodies of women of advanced age. | Q50653770 | ||
Differential effects of repeated ovarian stimulation on cytoplasmic and spindle organization in metaphase II mouse oocytes matured in vivo and in vitro. | Q50716927 | ||
Birth of healthy children after preimplantation diagnosis of common aneuploidies by polar body fluorescent in situ hybridization analysis. Preimplantation Genetics Group. | Q50761621 | ||
Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. | Q51678170 | ||
[Contribution of first polar body analysis to understanding of human aneuploidy mechanism]. | Q53620387 | ||
[The cytogenetics of human oocytes: 40 years of progress] | Q53674410 | ||
Treatment-related chromosome abnormalities in human embryos | Q57779469 | ||
Cytogenetic analysis of unfertilized oocytes retrieved after treatment with the LHRH analogue, buserelin | Q68368809 | ||
Comprehensive chromosomal analysis of human preimplantation embryos using whole genome amplification and single cell comparative genomic hybridization | Q73108832 | ||
Chromosome analysis of blastomeres from human embryos by using comparative genomic hybridization | Q73621662 | ||
Elevated day 3 serum follicle stimulating hormone and/or estradiol may predict fetal aneuploidy | Q77323484 | ||
[Maternal age and chromosomal abnormalities in human oocytes] | Q80493031 | ||
Advanced maternal age--how old is too old? | Q80961581 | ||
Preimplantation genetic screening reveals a high incidence of aneuploidy and mosaicism in embryos from young women undergoing IVF | Q81196488 | ||
Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial | Q81533938 | ||
P433 | issue | 10 | |
P304 | page(s) | 1123-1134 | |
P577 | publication date | 2012-08-14 | |
P1433 | published in | Journal of Assisted Reproduction and Genetics | Q15755113 |
P1476 | title | Follicular fluid protein content (FSH, LH, PG4, E2 and AMH) and polar body aneuploidy | |
P478 | volume | 29 |
Q36625099 | Activin Decoy Receptor ActRIIB:Fc Lowers FSH and Therapeutically Restores Oocyte Yield, Prevents Oocyte Chromosome Misalignments and Spindle Aberrations, and Increases Fertility in Midlife Female SAMP8 Mice |
Q64115264 | Anti-Müllerian Hormone Gene Polymorphism is Associated with Clinical Pregnancy of Fresh IVF Cycles |
Q35186882 | Preliminary proteomic analysis on the alterations in follicular fluid proteins from women undergoing natural cycles or controlled ovarian hyperstimulation |
Q47176567 | Relationship between follicular volume and oocyte competence, blastocyst development and live-birth rate: optimal follicle size for oocyte retrieval. |
Search more.